[1]
2022. Evaluation of CD4+, CD39+, FOXP3+Tregulatory cells in Iraqi Alopecia areata patients by ELISA. Journal of Pharmaceutical Negative Results. 13, (Oct. 2022), 247–250. DOI:https://doi.org/10.47750/pnr.2022.13.S05.32.